Structure |
Chemical Name |
CAS |
MF |
|
Alogliptin Imp.13 |
|
|
|
Alogliptin Related Compound 14 |
1820685-30-0 |
C18H23N5O3 |
|
Alogliptin benzoate impurity K |
1618644-32-8 |
C25H25N5O3 |
|
Amoxicillin Impurity P |
|
C16H19N3O5S |
|
N-Des-tetrahydrofuran N-(6,7-Dimethoxy-4,4a-dihydroquinazolin-4-amine) Alfuzosin |
928780-95-4 |
C24H30N8O4 |
|
Afatinib Impurity 50 |
|
|
|
Afatinib Impurity 75 |
2348580-72-1 |
C7H14N2O |
|
Acarbose Impurity IV (JP) |
|
C13H21NO7 |
|
Azlocillin Impurity 8 |
|
|
|
3,4-Dihydro-7-(4-chlorobutoxy)-2(1H)-quinolinone |
120004-79-7 |
C13H16ClNO2 |
|
Calcium bis[4-{[(1S,3R)-1-([1,1'-biphenyl]-4-ylmethyl)-3-methyl-4-oxo-4-(propan-2-yloxyl)butyl]amino}-4-oxobutanoate] |
|
C50H60CaN2O10 |
|
2,3-Dehydrosilybin B |
142796-24-5 |
C25H20O10 |
|
monocalciummono(4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy- 4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate) |
|
C24H28CaNO5 |
|
3-methyl-2-pentylphenol |
1823068-39-8 |
C12H18O |
|
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-7-[(2-phenylacetyl)amino]-, (4-methoxyphenyl)methyl ester, (6R,7R)- |
104146-11-4 |
C29H27N3O5S2 |
|
diltiazem hydrochloride |
103532-27-0 |
C22H27ClN2O4S |
|
2'-[(1H-Tetrazol-5-yl)biphenyl-4-yl]Methanol |
160514-13-6 |
C14H12N4O |
|
(2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid |
1639970-62-9 |
C22H23NO4 |
|
Ofloxacin/Levofloxacin Impurity A |
|
|
|
(R,R)-Palonosetron N-Oxide |
|
C19H24N2O2 |
|
7-PACE Impurity 2 |
|
|
|
Desloratadine IMpurity 3 |
1346600-61-0 |
C19H19ClN2 |
|
EMpagliflozin iMpurity 11 |
|
|
|
LCZ Impurity |
753421-85-1 |
C20H25NO2 |
|
(3S,5R)-4-[5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl]-4-oxobutanoic acid |
|
C22H23NO4 |
|
Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-4-[4-(propan-2-yloxy)-4-oxobutanamido]-2-methylbutanoate |
|
C27H35NO5 |
|
Formoterol EP Impurity E |
1616967-26-0 |
C20H26N2O4 |
|
(Glu3)-Carbetocin (Impurity D) |
|
|
|
Δ3-7-ACT |
|
|
|
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid hydrochloride |
1038924-71-8 |
C18H22ClNO2 |
|
(2S,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester,calcium salt(2:1) |
|
|
|
ethyl(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(4-ethoxy-4-oxobutanamido)-2-methylpentanoate |
|
C26H33NO5 |
|
phenyl (4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)carbamate |
417722-95-3 |
C24H18ClN3O5 |
|
Lacosamide Impurity – K |
|
|
|
(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1-[(1R,4S)-1,4,5-trimethylhexyl]-1H-Indene |
2229745-37-1 |
C40H74O2Si2 |
|
Ofloxacin/Levofloxacin Impurity B |
|
|
|
(2R,4S)-isopropyl5-([1,1'-biphenyl]-4-yl)-4-(2,5-dioxopyrrolidin-1- yl)-2-methylpentanoate |
|
C25H29NO4 |
|
Amylmetacresol EP impurity A |
876473-73-3 |
C12H18O |
|
5-methyl-2-(2-methylbutyl)phenol |
|
C12H18O |
|
7-ADCA Impuirty 1 |
|
|
|
7-PACE Impurity 1 |
|
|
|
(R)-Fluvastatin EP Impurity E |
|
|
|
5-(2-cyclopropyl-2-oxo-1-phenylethyl)-4,5,6,7-tetrahydrothieno [3,2-c]pyridin-2-yl acetate |
1391194-45-8 |
C20H21NO3S |
|
(Gly8-OH)-Carbetocin (Impurity B) |
|
|
|
D-Asn4-Carbetocin (Impurity F) |
|
|
|
5-Chloro AcesulfaMe |
72827-08-8 |
C4H4ClNO4S |
|
Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoate |
1038924-97-8 |
C24H27NO4 |
|
3'-chloro-3'-deoxythymidine (zidovudine impurity) |
|
|
|
Ofloxacin/Levofloxacin Impurity E |
|
|
|
4-(4-Hydroxy-3-hydroxymethyl-phenoxy)-benzonitrile |
|
C14H11NO3 |
|
monocalciummono(4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5- methoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate) |
|
C23H26CaNO5 |
|
(2R,4S)-Isopropyl 5-([1,1''-biphenyl]-4-yl)-4-(4-isopropoxy-4-oxobutanamido)-2-methylpentanoate |
2216755-67-6 |
C28H37NO5 |
|
EP Impurity Catalog |
|
|
|
2,4,6,3',5'-pentamethoxybiphenyl |
84212-55-5 |
C17H20O5 |
|
1-Azetidinesulfonamide(9CI) |
654073-32-2 |
C3H8N2O2S |
|
N-DESMETHYLGALANTHAMINE |
41303-74-6 |
C16H19NO3 |
|
Hydroxy Adapalene |
1346599-76-5 |
C28H28O4 |
|
Adefovir iMpurity |
1875153-79-9 |
C15H24N5O6P |
|
tert-butyl 4-cyclohexylpiperazine-1-carboxylate |
1224935-95-8 |
C15H28N2O2 |
|
Avanafil iMpurity 1 |
372117-54-9 |
C18H22ClN5O3 |
|
Avanafil Impurity 9 |
|
|
|
Afatinib Impurity 17 |
1870880-09-3 |
C20H18Cl2FN5O |
|
Abiraterone Impurity 4 |
2118-32-3 |
C23H34O2 |
|
4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine |
570407-42-0 |
C17H23ClN4S2 |
|
T-IRR |
|
|
|
Avatrombopag Impurity 23 |
|
|
|
Avatrombopag Impurity 34 |
|
|
|
3-Chloro Avanafil |
|
|
|
Avanafil IMpurity 8 (R-Avanafil) |
|
|
|
570403-04-2 |
570403-04-2 |
C23H24Cl3N5OS2 |
|
5-chloro-6-[4-(ethoxycarbonyl)piperidino]nicotinic acid |
931395-73-2 |
C14H17ClN2O4 |
|
Afatinib Impurity 14 |
|
|
|
Avanafil Impurity 10 |
|
|
|
Adefovir Impurity 2 |
|
|
|
Abacavir Impurity F |
1443421-68-8 |
C18H26N6O |
|
Albendazole EP Impurity J |
946498-41-5 |
C9H7Cl2N3O2 |
|
Afatinib impurity 33 |
|
|
|
Abitrone project impurity |
|
|
|
1364671-52-2 |
1364671-52-2 |
C19H19ClN6O3S |
|
Sugammadex disulfide Impurity |
|
|
|
2-Thiazolamine, 5-bromo-4-(5-bromo-4-chloro-2-thienyl)- |
2401867-89-6 |
C7H3Br2ClN2S2 |
|
Avatrombopag Impurity 31 |
|
|
|
Avatrombopag Impurity 75 |
|
|
|
N4,N7-bis(3-chloro-4-fluorophenyl)-8-nitroquinazoline-4,7-diamine |
|
|
|
Abiraterone Sulfate |
|
|
|
Avanafil iMpurity 5 |
|
|
|
Adefovir Dipivoxil Impurity E |
116384-54-4 |
C10H16N5O4P |
|
Afatinib Impurity 22 |
|
|
|
Adefovir Impurity 6 |
|
|
|
Afatinib impurity 30 |
|
|
|
N - hydroxy Tropisetron Impurity 2 |
|
|
|
2-bromo-1-(4-chlorothiophen-2-yl)ethanone |
677007-73-7 |
C6H4BrClOS |
|
3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-1,6-dihydro-6-oxo- |
762237-66-1 |
C23H25Cl2N5O2S2 |
|
Avatrombopag Impurity 54 |
|
|
|
(Asp4)-Carbetocin (Impurity G) |
|
|
|
((1R,3R,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-diMethylhept-3-en-2-yl)-7a-Methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-Methylenecyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldiMethylsilane) |
115540-28-8 |
C40H72O2Si2 |
|
(S,R)-Palonosetron N-Oxide |
|
C19H24N2O2 |
|
2-Hydroxymethyl Olanzapine |
174756-45-7 |
C17H20N4OS |
|
Flomoxef Impurity 2 |
|
|
|
4-Isobutylacetophenone (Ibuprofen impurity) |
|
|